Search

Author/Creator Deleu, Sofie

1. A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study . (1st July 2020)

Authors:
O'Neil, Brian; Ison, Michael G; Hallouin-Bernard, Marie Charlotte; Nilsson, Anna C; Torres, Antoni; Wilburn, John M; van Duijnhoven, Wilbert; Van Dromme, Ilse; Anderson, David; Deleu, Sofie; Kosoglou, Teddy; Vingerhoets, Johan; Rossenu, Stefaan; Leopold, Lorant
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 1(2022)
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Absence of QTc prolongation with domperidone: A randomized, double‐blind, placebo‐ and positive‐controlled thorough QT/QTc study in healthy volunteers. Issue 1 (30th May 2014)

Authors:
Biewenga, Jeike; Keung, Chi; Solanki, Bhavna; Natarajan, Jaya; Leitz, Gerhard; Deleu, Sofie; Soons, Paul
Journal:
Clinical pharmacology in drug development
Issue:
Volume 4:Issue 1(2015:Jan./Feb.)
Page Start:
41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers. (14th September 2018)

Authors:
Deleu, Sofie; Kakuda, Thomas N.; Spittaels, Kurt; Vercauteren, Jurgen J.; Hillewaert, Vera; Lwin, Amy; Leopold, Lorant; Hoetelmans, Richard M. W.
Journal:
British journal of clinical pharmacology
Issue:
Volume 84:Number 11(2018)
Page Start:
2663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗